199 related articles for article (PubMed ID: 37030332)
21. BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZ.
Lai D; Yang X
Cell Signal; 2013 Aug; 25(8):1720-8. PubMed ID: 23673366
[TBL] [Abstract][Full Text] [Related]
22. FTO facilitates cancer metastasis by modifying the m
Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
[TBL] [Abstract][Full Text] [Related]
23. LncRNA NOC2L-4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR-630/YAP1 pathway.
Wang Q; Ding J; Nan G; Lyu Y; Ni G
J Cell Biochem; 2019 Oct; 120(10):16913-16920. PubMed ID: 31099044
[TBL] [Abstract][Full Text] [Related]
24. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
25. ZWINT promotes the proliferation, migration, and invasion of cervical cancer cells by regulating the p53/p21 signaling pathway.
Ma Z; Cai Y; Tian C
Chin J Physiol; 2023; 66(5):372-378. PubMed ID: 37929349
[TBL] [Abstract][Full Text] [Related]
26. FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13.
Liu S; Huang M; Chen Z; Chen J; Chao Q; Yin X; Quan M
Exp Cell Res; 2020 Apr; 389(1):111894. PubMed ID: 32035950
[TBL] [Abstract][Full Text] [Related]
27. Upregulated microRNA let-7a accelerates apoptosis and inhibits proliferation in uterine junctional zone smooth muscle cells in adenomyosis under conditions of a normal activated hippo-YAP1 axis.
Huang JH; Duan H; Wang S; Wang YY; Lv CX
Reprod Biol Endocrinol; 2021 Jun; 19(1):81. PubMed ID: 34082774
[TBL] [Abstract][Full Text] [Related]
28. Phenethyl isothiocyanate inhibits metastasis potential of non-small cell lung cancer cells through FTO mediated TLE1 m
Zhang QC; Qian YM; Ren YH; Chen MM; Cao LM; Zheng SJ; Li BB; Wang M; Wu X; Xu K
Acta Pharmacol Sin; 2024 Mar; 45(3):619-632. PubMed ID: 37848553
[TBL] [Abstract][Full Text] [Related]
29. CircGPR137B/miR-4739/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma.
Liu L; Gu M; Ma J; Wang Y; Li M; Wang H; Yin X; Li X
Mol Cancer; 2022 Jul; 21(1):149. PubMed ID: 35858900
[TBL] [Abstract][Full Text] [Related]
30. Demethylase FTO enhances the PI3K/Akt signaling to promote gastric cancer malignancy.
Zhu Y; Yang J; Li Y; Xu J; Fang Z
Med Oncol; 2023 Mar; 40(5):130. PubMed ID: 36971873
[TBL] [Abstract][Full Text] [Related]
31. Fat mass and obesity-associated protein (FTO) mediated m
Wu X; Fang Y; Gu Y; Shen H; Xu Y; Xu T; Shi R; Xu D; Zhang J; Leng K; Shu Y; Ma P
Mol Biomed; 2024 Apr; 5(1):11. PubMed ID: 38556586
[TBL] [Abstract][Full Text] [Related]
32. GABAB receptor inhibits tumor progression and epithelial-mesenchymal transition via the regulation of Hippo/YAP1 pathway in colorectal cancer.
Wang H; Zhang H; Sun Z; Chen W; Miao C
Int J Biol Sci; 2021; 17(8):1953-1962. PubMed ID: 34131398
[TBL] [Abstract][Full Text] [Related]
33. Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9.
Wang C; Wang Y; Liu C; Meng X; Hang Z
Bioengineered; 2022 Apr; 13(4):9495-9507. PubMed ID: 35389773
[TBL] [Abstract][Full Text] [Related]
34. Yes-associated protein 1 exerts its tumor-promoting effects and increases cisplatin resistance in tongue squamous cell carcinoma cells by dysregulating Hippo signal pathway.
Guan H; Deng L
Anticancer Drugs; 2022 Apr; 33(4):352-361. PubMed ID: 35266885
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
36. FTO demethylates YAP mRNA promoting oral squamous cell carcinoma tumorigenesis.
Li DQ; Huang CC; Zhang G; Zhou LL
Neoplasma; 2022 Jan; 69(1):71-79. PubMed ID: 34779644
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA LUADT1 promotes nasopharyngeal carcinoma cell proliferation and invasion by downregulating miR-1207-5p.
Jiang N; Zhao L; Zong D; Yin L; Wu L; Chen C; Song X; Zhang Q; Jiang X; He X; Feng J
Bioengineered; 2021 Dec; 12(2):10716-10728. PubMed ID: 34738862
[TBL] [Abstract][Full Text] [Related]
38. PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.
Zhang Y; Zhou X; Cheng X; Hong X; Jiang X; Jing G; Chen K; Li Y
Neoplasma; 2022 Dec; 69(6):1338-1348. PubMed ID: 36305690
[TBL] [Abstract][Full Text] [Related]
39. SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis.
Ren D; Sun Y; Zhang D; Li D; Liu Z; Jin X; Wu H
Cancer Lett; 2021 Oct; 519():277-288. PubMed ID: 34314754
[TBL] [Abstract][Full Text] [Related]
40. FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.
Sun Z; Sun X; Qin G; Li Y; Zhou G; Jiang X
Epigenetics; 2023 Dec; 18(1):2242688. PubMed ID: 37538000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
